Health Canada18 Aug 2026
Unauthorized drugs seized from Rabais 4Saisons Inc. in Montreal, QC, may pose serious health risks
Health Canada published a recall notice for Unauthorized drugs seized from Rabais 4Saisons Inc. in Montreal, QC, may pose serious health risks on 18 Aug 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 18 Aug 2026
- Recall type
- Public advisory
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: Health Canada has seized several unauthorized drugs (including an oral emergency contraceptive drug, erectile dysfunction drugs, and antibiotic and antiparasitic drugs) from Rabais 4Saisons Inc. (5321 rue de Charleroi), in Montreal, Quebec, because they may pose serious health risks. Selling unauthorized health products in Canada is illegal. Unauthorized health products have not been approved by Health Canada, which means they have not been assessed for safety, effectiveness and quality and may pose serious health risks. For example, they may lack active ingredients, vary in their concentration or contain ingredients, additives or contaminated ingredients not listed on the label that could interact with other medications and foods. Many of the seized products are unauthorized versions of prescription drugs available in Canada. Prescription drugs should be used only under the supervision of a health care professional because they are used to treat specific conditions and may cause serious side effects. Several of the products are not labelled in English and French as required in Canada. As a result, information about ingredients, usage, dosage and side effects may not be available to or understood by consumers. Health Canada acts to protect public health and safety when companies are found to be selling unauthorized health products in Canada, including warning consumers when warranted. The Department also works with the Canada Border Services Agency to help prevent the import of any unauthorized health products. What you should do What to do: Do not buy or use unauthorized health products. Consult with a licensed healthcare professional (physician, nurse practitioner, pharmacist) if you have used these products and have health concerns. Check if your health products are authorized. Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM). You can also check whether products are authorized for sale by searching Health Canada's Drug Product Database or Licensed Natural Health Products Database. Report any health product-related side effects or complaints to Health Canada. Additional information Background Affected products: Various unauthorized health products, including prescription drugs Product Prescription drug After-D Labelled to contain levonorgestrel Albendazol Labelled to contain albendazole Balaxi – Amoxicilina Labelled to contain amoxicillin Balaxi – Tetraciclina Labelled to contain tetracycline Black Horse Vital Honey Product with similar packaging (previously seized) was tested and found to contain sildenafil Caplin Point Labelled to contain ampicillin Erix Labelled to contain sildenafil Saad – Ampicilina Labelled to contain ampicillin Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.